Claim Missing Document
Check
Articles

Found 32 Documents
Search

EVALUASI PENGGUNAAN OBAT ANTIHIPERTENSI PADA PASIEN HIPERTENSI DI UPTD PUSKESMAS JUANDA KOTA SAMARINDA Wijikinasih, Wijikinasih; Muh. Taufiqurrahman; Raymon Simanullang
Jurnal Riset Kefarmasian Indonesia Vol. 7 No. 3 (2025): Jurnal Riset Kefarmasian Indonesia
Publisher : APDFI (Asosiasi Pendidikan Diploma Farmasi Indonesia)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33759/v7i3.771

Abstract

The increasing use of antihypertensive drugs may raise the potential for irrational use. Irrational management of hypertension can worsen the patient’s condition and trigger complications such as stroke, heart disease, and kidney failure. This study was a descriptive study with retrospective data collection using purposive sampling. Data were obtained from electronic medical records in the e-Puskesmas application of hypertensive patients. The results showed that 85.8% of antihypertensive drug use was in accordance with hypertension management based on the Decree of the Minister of Health of the Republic of Indonesia No. HK.01.07/MENKES/1936/2022 on Clinical Practice Guidelines for Physicians in Primary Healthcare Facilities (PHC) and the JNC VIII Guidelines. These findings indicate that most antihypertensive drug use in primary healthcare facilities has followed current management standards, although approximately 14.2% of cases still demonstrate potential irrational use. This highlights the need for continuous evaluation and improved adherence to clinical guidelines in order to minimize the risk of complications.
Sunscreen Activity Test of Tahongai (Kleinhovia hospita L) Leaves Infusion use UV-Vis Spectrophotometry Method Butar-Butar, Maria Elvina Tresia; Sianturi, Sister; Leswana, Nurillahi Febria; Muh. Taufiqurrahman
JURNAL FARMASI GALENIKA Vol 13 No 1 (2026): Jurnal Farmasi Galenika Volume 13 No 1
Publisher : Universitas Bhakti Kencana

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70410/jfg.v13i1.425

Abstract

Excessive frequency and duration of UV exposure causes adverse effects, including erythema, pigmentation, premature aging, and even skin cancer. Therefore, additional protection is required, such as the use of sunscreen. The development of natural active ingredients is necessary to reduce the negative impact of sunscreen products. Tahongai (Kleinhovia hospita L) contains flavonoid compounds that have the potential as sunscreens due to the presence of chromophore groups that can absorb UVA and UVB rays. The purpose of this study was to determine the potential of tahongai leaf infusion as a sunscreen. The test method of sunscreen activity was carried out in-vitro using UV-Vis spectrophotometry. The sunscreen activity test was carried out by calculating the percent transmission value (%Te), the percent transmission value of pigmentation (%Tp), and the SPF value. The results of the calculation of %Te, %Tp, and SPF values, as well as the sunscreen category at a concentration of 0.5 g are %Te of 3.368 (extra protection), %Tp of 1.248 (sunblock), and SPF value of 21.945 (ultra protection). Tahongai leaf infusion has potential as an active ingredient for sunscreen products and still requires further in vivo research to ensure its effectiveness as well as the duration of its protection